New preclinical evidence shows that oral arginine reduces toxic amyloid structures and eases behavioral impairments in Alzheimer’s models, highlighting a potential therapeutic path that now requires careful human dose and safety…
Arginine slows amyloid buildup and improves brain outcomes in Alzheimer’s disease models
